J. Kraus et al., CD45RA(+) ICAM-3(+) lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosis, ACT NEUR SC, 102(5), 2000, pp. 326-332
Objectives - Autoreactive T cells targeted against antigens of the myelin s
heath are suggested to play an important role in the pathogenesis of multip
le sclerosis (MS). Naive (CD45RA(+))T cells and intercellular adhesion mole
cule-3 (ICAM-3) are markers for un-activated lymphocytes. This study was pe
rformed to investigate, whether the expression levels of these antigens bot
h on cerebrospinal fluid (CSF) and peripheral blood lymphocytes can be used
as activity markers in MS. Materials and methods - Corresponding blood and
CSF samples were obtained from 31 patients with relapsing-remitting MS. Of
the 31 MS patients 23 were suffering from acute relapses at the time of ex
amination and all of them were treated with high-dose methylprednisolone (M
P). Blood was collected again on the 10th day of therapy and after 3 months
. The control group consisted of 12 healthy persons. Two-color flow cytomet
ry was performed to evaluate the percentage of both CD45RA(+) and ICAM-3(+)
cells within the lymphocyte population. Results - The percentage of CD45RA
(+) ICAM-3(+) cells in the CSF of MS patients with relapses was significant
ly increased compared to patients in remission (P<0.05). In blood, a signif
icantly lower percentage of CD45RA(+) ICAM-3(+) lymphocytes was found in bo
th patient groups compared to healthy controls (Relapse: P<0.05, Remission:
P<0.10). Additionally, we found a significant increase (P<0.01) in the per
centage of CD45RA(+) ICAM-3(+) lymphocytes in blood of MS patients sufferin
g from acute relapse on the 10th day of high-dose MP treatment. Conclusion
- Our data suggest that the percentage of CD45RA(+) ICAM-3(+) lymphocytes i
n CSF can be used as marker of disease activity in MS patients.